Glucose Health, Inc. (GLUC) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
609 SW 8TH STREET BENTONVILLE, AR 72712 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 21 | 2 | 10 | 1 | 2 | ||
| Cash and cash equivalents | 21 | 2 | 10 | 1 | 2 | ||
| Receivables | 12 | 3 | |||||
| Inventory, net of allowances, customer advances and progress billings | 8 | 25 | ✕ | ||||
| Inventory | 8 | 25 | |||||
| Prepaid expense | 1 | 1 | 39 | ✕ | |||
| Other undisclosed current assets | 0 | (5) | (1) | (1) | |||
| Total current assets: | 33 | 15 | 44 | 26 | 1 | ||
| Noncurrent Assets | |||||||
| Intangible assets, net (including goodwill) | 0 | 0 | 0 | ✕ | 207 | ||
| Intangible assets, net (excluding goodwill) | 0 | 0 | 0 | 207 | |||
| Total noncurrent assets: | 0 | 0 | 0 | 207 | |||
| TOTAL ASSETS: | 33 | 15 | 44 | 26 | 208 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 138 | 95 | 155 | 145 | 123 | ||
| Accrued liabilities | 5 | 0 | |||||
| Other undisclosed accounts payable and accrued liabilities | 133 | 95 | 155 | 145 | 123 | ||
| Debt | 39 | 6 | 170 | 86 | 121 | ||
| Deferred compensation liability | (17) | (150) | |||||
| Due to related parties | 112 | 2 | 2 | ||||
| Other undisclosed current liabilities | 240 | 302 | 8 | 89 | |||
| Total current liabilities: | 529 | 403 | 325 | 223 | 185 | ||
| Noncurrent Liabilities | |||||||
| Total liabilities: | 529 | 403 | 325 | 223 | 185 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent, including: | (495) | (388) | (281) | (198) | 22 | ||
| Preferred stock | 113 | 113 | 113 | ||||
| Common stock | 3 | 2 | 1 | 19 | 101 | ||
| Common stock, value, subscriptions | 23 | 23 | ✕ | ✕ | |||
| Additional paid in capital | 120 | 5,386 | 5,228 | 4,743 | 3,589 | ||
| Accumulated other comprehensive loss | (75) | (75) | (75) | (75) | (75) | ||
| Accumulated deficit | (6,248) | (5,837) | (5,571) | (2,874) | (2,874) | ||
| Other undisclosed stockholders' equity attributable to parent | 5,568 | 23 | (2,011) | (719) | |||
| Total stockholders' equity: | (495) | (388) | (281) | (198) | 22 | ||
| TOTAL LIABILITIES AND EQUITY: | 33 | 15 | 44 | 26 | 208 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|
| Revenues | 313 | 4 | 3 | |||
| Revenue, net | 313 | 4 | 3 | (0) | ||
| Cost of revenue | (294) | (4) | (3) | (2) | (16) | |
| Cost of goods and services sold | (4) | (23) | (200) | (16) | ||
| Other undisclosed gross profit | (21) | 0 | ||||
| Gross profit: | 19 | 0 | (21) | (2) | (16) | |
| Operating expenses | (106) | (157) | (524) | (1,267) | (361) | |
| Other undisclosed operating income | 16 | |||||
| Operating loss: | (87) | (156) | (545) | (1,269) | (361) | |
| Nonoperating expense | (324) | (110) | (124) | (190) | (38) | |
| Debt instrument, convertible, beneficial conversion feature | (110) | (173) | (34) | |||
| Interest and debt expense | (324) | (120) | (110) | (169) | (38) | |
| Loss from continuing operations before equity method investments, income taxes: | (734) | (386) | (779) | (1,628) | (437) | |
| Other undisclosed income from continuing operations before income taxes | 324 | 120 | 110 | 169 | ||
| Loss before gain (loss) on sale of properties: | (410) | (266) | (669) | (1,459) | (437) | |
| Other undisclosed net income | 32 | |||||
| Net loss: | (410) | (266) | (669) | (1,459) | (405) | |
| Other undisclosed net income attributable to parent | 6 | |||||
| Net loss available to common stockholders, diluted: | (410) | (266) | (669) | (1,459) | (399) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|
| Net loss: | (410) | (266) | (669) | (1,459) | (405) | |
| Comprehensive loss, net of tax, attributable to parent: | (410) | (266) | (669) | (1,459) | (405) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.